Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer

NCT00298155 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Prostate Neoplasms

Interventions

DRUG: goserelin with dutasteride
DRUG: goserelin with bicalutamide and dutasteride
DRUG: goserelin with bicalutamide and dutasteride and ketoconazole

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]